E J Irvine

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi request reprint Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
    E J Irvine
    Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Gastroenterology 119:1740-4. 2000
  2. ncbi request reprint Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide
    J K Marshall
    Department of Medicine, McMaster University, Hamilton, Ontario
    Can J Gastroenterol 11:501-2. 1997
  3. ncbi request reprint A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls
    S C Ganguli
    Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada
    Neurogastroenterol Motil 19:961-7. 2007
  4. ncbi request reprint Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England
    F Farrokhyar
    Division of Clinical Sciences, University of Wolverhampton, England, United Kingdom
    Am J Gastroenterol 96:501-7. 2001
  5. pmc Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease
    M Zareie
    Intestinal Disease Research Program, McMaster University, 1200 Main St. West, Hamilton, Ontario, L8N 3Z5, Canada
    Am J Pathol 158:1101-9. 2001
  6. ncbi request reprint Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis
    S Bloom
    Department of Gastroenterology, The Middlesex Hospital, London, UK
    Aliment Pharmacol Ther 19:871-8. 2004
  7. ncbi request reprint Review article: patients' fears and unmet needs in inflammatory bowel disease
    E J Irvine
    Division of Gastroenterology, University of Toronto, Ontario, Canada
    Aliment Pharmacol Ther 20:54-9. 2004
  8. ncbi request reprint Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease
    W H Ren
    Department of Nursing, Second Affiliated Hospital, College of Medicine, Zhejiang University, PR China
    Inflamm Bowel Dis 13:903-10. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
    E J Irvine
    Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Gastroenterology 119:1740-4. 2000
    ..This observation provides support for the hypothesis that increased gut permeability to macromolecules is an early step in the pathogenesis of this disorder...
  2. ncbi request reprint Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide
    J K Marshall
    Department of Medicine, McMaster University, Hamilton, Ontario
    Can J Gastroenterol 11:501-2. 1997
    ..While the mechanism of action of this agent is poorly understood, it appears to be an effective and nontoxic therapy for Crohn's-related erythema nodosum and warrants further evaluation in a placebo controlled trial...
  3. ncbi request reprint A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls
    S C Ganguli
    Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada
    Neurogastroenterol Motil 19:961-7. 2007
    ..UC patients have an increased sympathetic ANS activity which is independent of symptom severity. In these patients symptom severity is strongly associated with measures of personality related (but not current) anxiety...
  4. ncbi request reprint Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England
    F Farrokhyar
    Division of Clinical Sciences, University of Wolverhampton, England, United Kingdom
    Am J Gastroenterol 96:501-7. 2001
    ..001). CONCLUSIONS: Mortality rates are not increased in IBD compared with the general population. However, older patients may be at increased risk of dying from other causes early in the disease clinical course...
  5. pmc Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease
    M Zareie
    Intestinal Disease Research Program, McMaster University, 1200 Main St. West, Hamilton, Ontario, L8N 3Z5, Canada
    Am J Pathol 158:1101-9. 2001
    ..We conclude that LPMCs of patients with Crohn's disease are spontaneously activated, possibly by gram-negative luminal bacteria, and can directly cause significant alterations in epithelial ion transport and barrier functions...
  6. ncbi request reprint Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis
    S Bloom
    Department of Gastroenterology, The Middlesex Hospital, London, UK
    Aliment Pharmacol Ther 19:871-8. 2004
    ..Heparin has anti-inflammatory and immunomodulatory activity which may be of therapeutic benefit in the treatment of ulcerative colitis...
  7. ncbi request reprint Review article: patients' fears and unmet needs in inflammatory bowel disease
    E J Irvine
    Division of Gastroenterology, University of Toronto, Ontario, Canada
    Aliment Pharmacol Ther 20:54-9. 2004
    ....
  8. ncbi request reprint Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease
    W H Ren
    Department of Nursing, Second Affiliated Hospital, College of Medicine, Zhejiang University, PR China
    Inflamm Bowel Dis 13:903-10. 2007
    ....